Skip to main content
OpenTrials

Clinical trial condition

Acquired Bleeding Disorder

Explore clinical trials studying Acquired Bleeding Disorder. Study availability and eligibility vary by location and protocol.

22 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Acquired Bleeding Disorder trial results

Completed

Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart Surgery

NCT00914589

Conditions
Acquired Bleeding Disorder, Cardiac Surgery Requiring Cardiopulmonary Bypass
Locations
  • Novo Nordisk Investigational Site Atlanta, Georgia, United States
  • Novo Nordisk Investigational Site Durham, North Carolina, United States
  • Novo Nordisk Investigational Site Portland, Oregon, United States
  • Novo Nordisk Investigational Site Allentown, Pennsylvania, United States
View all 32 locations
View Trial Details
Completed

Recombinant Factor VIIa in Acute Intracerebral Haemorrhage

NCT00426803

Conditions
Acquired Bleeding Disorder, Brain Diseases, Cardiovascular Diseases, +10 more
Locations
  • Novo Nordisk Investigational Site Melbourne, Australia
  • Novo Nordisk Investigational Site Graz, Austria
  • Novo Nordisk Investigational Site Antwerp, Belgium
  • Novo Nordisk Investigational Site Calgary, Canada
View all 15 locations
View Trial Details
Completed

Safety and Efficacy of Activated Recombinant Human Factor VII in Cirrhotic Patients Undergoing Partial Hepatectomy

NCT01562821

Conditions
Acquired Bleeding Disorder, Cirrhosis, Fibrosis, +2 more
Locations
  • Novo Nordisk Investigational Site Beijing, Beijing Municipality, China
  • Novo Nordisk Investigational Site Shanghai, Shanghai Municipality, China
  • Novo Nordisk Investigational Site Beijing, China
  • Novo Nordisk Investigational Site Taipei, Taiwan
View Trial Details
Completed

Use of Activated Recombinant FVII in Spinal Surgery

NCT00102037

Conditions
Acquired Bleeding Disorder, Spinal Fusion
Locations
  • Novo Nordisk Investigational Site Sacramento, California, United States
  • Novo Nordisk Investigational Site San Francisco, California, United States
  • Novo Nordisk Investigational Site Washington D.C., District of Columbia, United States
  • Novo Nordisk Investigational Site Miami, Florida, United States
View all 14 locations
View Trial Details
Completed

Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Undergoing Orthotopic Liver Transplantation

NCT01563458

Conditions
Acquired Bleeding Disorder, Bleeding During/Following Surgery
Locations
  • Novo Nordisk Investigational Site Camperdown, Australia
  • Novo Nordisk Investigational Site Heidelberg, Australia
  • Novo Nordisk Investigational Site Vancouver, British Columbia, Canada
  • Novo Nordisk Investigational Site London, Canada
View all 18 locations
View Trial Details
Completed

Use of NovoSeven® in Active Variceal Bleeding

NCT00154492

Conditions
Acquired Bleeding Disorder, Cirrhosis, Fibrosis, +2 more
Locations
  • Novo Nordisk Investigational Site Vienna, Austria
  • Novo Nordisk Investigational Site Olomouc, Czechia
  • Novo Nordisk Investigational Site Prague, Czechia
  • Novo Nordisk Investigational Site Prague, Czechia
View all 44 locations
View Trial Details

Related conditions